ENTA
Enanta Pharmaceuticals Inc
Price:  
12.03 
USD
Volume:  
60,589.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA WACC - Weighted Average Cost of Capital

The WACC of Enanta Pharmaceuticals Inc (ENTA) is 7.5%.

The Cost of Equity of Enanta Pharmaceuticals Inc (ENTA) is 7.45%.
The Cost of Debt of Enanta Pharmaceuticals Inc (ENTA) is 5.00%.

Range Selected
Cost of equity 6.10% - 8.80% 7.45%
Tax rate 2.00% - 2.50% 2.25%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.1% - 8.8% 7.5%
WACC

ENTA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.49 0.7
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 8.80%
Tax rate 2.00% 2.50%
Debt/Equity ratio 0.01 0.01
Cost of debt 5.00% 5.00%
After-tax WACC 6.1% 8.8%
Selected WACC 7.5%